Cerebrolysin
Cerebrolysin
Cerebrolysin is a peptide-based nootropic derived from purified porcine brain proteins, consisting of low-molecular-weight neuropeptides and amino acids that cross the blood-brain barrier. It is primarily used clinically for stroke recovery, traumatic brain injury rehabilitation, Alzheimer's disease, and vascular dementia, with off-label use as a cognitive enhancer. It is available as an injectable solution and is widely prescribed across Europe, Asia, and Latin America.
Mechanism of Action
Cerebrolysin exerts neurotrophic effects by mimicking endogenous brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), and other neurotrophins, promoting neuronal survival, differentiation, and synaptic plasticity. It inhibits calpain-mediated neurodegeneration, reduces amyloid precursor protein processing, and modulates glutamate excitotoxicity through NMDA receptor pathways. Additionally, it upregulates CREB signaling and promotes adult neurogenesis in the hippocampus, supporting memory consolidation and cognitive function.
Evidence by Health Goal(15 goals)
Dosing Protocols
Morning administration preferred; slow intravenous infusion diluted in saline for doses above 10mL, direct IM or slow IV push for lower doses
Cycle: 10-20 day clinical courses, repeated 2-4 times per year; off-label users often run 10-day cycles monthly
Clinical studies for stroke and dementia typically use 10-30mL IV daily for 10-21 days. Cognitive enhancement protocols commonly use 5-10mL IM or slow IV push. Must be administered by or under guidance of a medical professional. Product is a 1mL=43mg peptide fraction solution.
Safety & Side Effects
Cerebrolysin has a well-established safety profile in clinical trials spanning decades, with serious adverse events being rare when properly dosed and administered; however, it is a prescription medication in most countries and should not be self-administered without medical supervision. Patients with active epilepsy, severe renal impairment, or known hypersensitivity to porcine-derived products should avoid use, and infusion must be performed slowly to minimize cardiovascular side effects.
Possible Side Effects
- !Injection site discomfort, warmth, or mild pain (especially with IM administration)
- !Dizziness or lightheadedness during or after IV infusion
- !Headache, particularly with rapid infusion rates
- !Mild agitation or irritability in some users
- !Nausea or loss of appetite, more common at higher doses
- !Hypersensitivity or allergic reactions (rare but potentially serious)
- !Seizures in patients with pre-existing epilepsy (rare, dose-dependent)
Interactions
- -May potentiate effects of antidepressants (MAOIs, SSRIs) — concurrent use requires caution and medical oversight
- -Additive CNS effects possible with other nootropics or cholinergic agents such as alpha-GPC or donepezil
- -Should not be mixed in the same IV solution as amino acid infusions or lipid emulsions due to compatibility concerns
- -May lower seizure threshold interactions with medications that already reduce seizure threshold (e.g., tramadol, fluoroquinolones)
- -Theoretical additive neuroprotective benefit when combined with citicoline, though pharmacodynamic interactions are not fully characterized
Cost & Where to Buy
Cost varies significantly by country and source; Eastern European and Chinese generic versions are cheaper (~$80-150/month for a 10-day cycle), while branded Cerebrolysin from EVER Neuro Pharma runs $250-400 per treatment course. Sourced as a gray-market research product in the US, pricing reflects individual ampoule costs plus any compounding or import fees.
Search on Amazon